Categories AlphaGraphs, Earnings, Retail
Estée Lauder stock jumps as cosmetic giant crosses $4 billion in Q2 sales; profit soars
Cosmetics giant Estée Lauder Companies (EL) posted its second-quarter 2019 earnings before the bell on Tuesday, Feb. 5. Earnings grew 365% to $573 million or $1.55 per diluted share, while revenue rose 7% to $4.01 billion. Adjusted earnings grew 22% to $1.86 per share. The company’s stock jumped more than 10% in pre-market trade following the announcement.
Both top-line and bottom-line beat the Street expectations of earning $1.54 per adjusted share on revenue estimate of $3.92 billion.
“Our earnings per share in the second quarter grew more than twice the rate of net sales in constant currency, delivering an impressive first-half performance,” said CEO Fabrizio Freda.
“Our strongest growth engines this quarter included the skin care category globally, the Asia/Pacific region, the online and travel retail channels, and most brands, including Estée Lauder, La Mer, M•A•C and our artisanal fragrance brands,” Freda added.
LOOKING AHEAD
Estée Lauder continues to expect robust consumer demand for its products. “We continue to expect global prestige beauty to grow 5% to 6% during the fiscal year,” read the statement by the company that owns M•A•C.
Despite the impact of closing certain department store locations in the United States and the United Kingdom, and costs associated with the upcoming anticipated Brexit in the UK, Estée Lauder looks to outperform the industry.
In the third quarter of fiscal 2019, Estée Lauder sees net sales growing 5-6% year-over-year, including a 5% impact from currency translation and a 2% benefit from the adoption of ASC 606 standards. Excluding these items, net sales is expected to grow 8-9%. Reported diluted net earnings per share is projected to be between $1.17 and $1.20. Excluding restructuring and other charges and adjustments, diluted net earnings is estimated at $1.26-1.28 per share.
For the full year 2019, the company expects to grow 5-9% in net sales, including the impact of external factors. Excluding these items, net sales are forecasted to grow between 8% and 9%. Reported diluted net earnings per share is projected to be between $4.55 and $4.67. Excluding restructuring and other charges and adjustments, diluted net earnings is projected at $4.92-5.00 per share.
Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on